Search company, investor...
Anteis company logo


Founded Year



Acquired | Acquired

About Anteis

Anteis is a strong global player in the area of injectable medical devices based on biopolymer transformation. Anteis has developed several highly innovative and highly differentiated products in the field of aesthetics, including dermal fillers, resorbable implants and cutaneous rehydration gels. Their product lines Esthelis, Fortelis, Mesolis and Modelis as well as the Jolidermis range and the Anteis Injection System are available in over 90 countries in five continents. In addition to their competency in aesthetic dermatology, Anteis is also active in the fields of ophthalmology and orthopedics.

Headquarters Location

Chemin des Aulx 18

Plan les Ouates, CH 1228,


+41 (0) 223 089 380

Missing: Anteis's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Anteis's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Anteis Patents

Anteis has filed 1 patent.

The 3 most popular patent topics include:

  • Biomaterials
  • Implants (medicine)
  • Polymers
patents chart

Application Date

Grant Date


Related Topics




EC 2.4.1, Food additives, Polysaccharides, Calcium compounds, Metabolism


Application Date


Grant Date



Related Topics

EC 2.4.1, Food additives, Polysaccharides, Calcium compounds, Metabolism



Latest Anteis News

Merz Pharma Group Acquires Swiss Aesthetics Company Anteis S.A.

Nov 11, 2013

Merz Pharma Group Frankfurt am Main announced that it has entered into a definitive agreement to acquire Anteis S.A. a Swiss company which specializes in the development manufacture and commercialization of medical devices in the ar...

Anteis Frequently Asked Questions (FAQ)

  • When was Anteis founded?

    Anteis was founded in 2003.

  • Where is Anteis's headquarters?

    Anteis's headquarters is located at Chemin des Aulx 18, Plan les Ouates.

  • What is Anteis's latest funding round?

    Anteis's latest funding round is Acquired.

  • Who are the investors of Anteis?

    Investors of Anteis include Merz Therapeutics and Signet Healthcare Partners.

  • Who are Anteis's competitors?

    Competitors of Anteis include Noraker, REGENESIS BIOMEDICAL, Microfabrica, Expanding Orthopedics, Micell Technologies and 12 more.

Compare Anteis to Competitors

Transcutaneous Technologies

Developing, manufacturing, selling and exporting transcutaneousndevices which will put physiologically active substances intonsubcutaneous tissue applying the theory of electrophoresis. Developing, manufacturing, selling, exporting and importing cosmetic devices, health enhancement devices and medical devices. nnDeveloping, manufacturing, selling, exporting and importing cosmetics. All businesses that are incidental or related to the businesses stated nin the preceding items.

Noraker Logo

Design, manufacturing and marketing of long term implantable medical devices dedicated to bone reconstruction for applications in orthopedic, spinal, dental and skull-maxillo-facial surgeries.The company's main aim is to conceive bioresorbable implants helping surgeons to improve patients' welfare.

Reva Medical

REVA Medical develops interventional medical devices that leverage the company's stent designs and biomaterials to improve the treatment of vascular disease. Its flagship product is called MOTIV, a bioresorbable coronary stent that is designed to fulfill the temporary need for a stent and then fade away, leaving only the healed vessel behind. This product is utilized for the treatment of coronary artery disease. REVA Medical has a broad strategic relationship with Boston Scientific Corporation, a worldwide developer and marketer of interventional medical devices. The company was founded in 1998 and is based in San Diego, California.


Biorthex is an orthopedic device manufacturer that develops manufactures and markets innovative spinal interbody fusion devices and instruments for the treatment of degenerative conditions of the human spine

Embolic Protection

Devices for the prevention of embolic complications including stroke and heart attack during interventional vascular procedures. Acquired by Boston Scientific in 2001.

Freedom Innovations Logo
Freedom Innovations

Freedom Innovations is a high technology provider of premium prosthetic devices, a growing segment of the non-invasive orthopedic market. It deals with making prosthetic devices with latest technological developments and customization for lower limb amputations. The branded carbon fiber foot products lead the industry in reputation and growth rate. The company's first microprocessor-controlled product, the Pli' MPC Knee, was introduced in May 2007, serving as an entry into the SMART technology arena.What aims to make the company and the products is the high customization in the prosthetic devices market ranging from different limbs for swimmers to bikers to soldiers and so on.In February 2012, Health Evolution Partners acquired a majority stake in Freedom Innovations. The valuation of Freedom Innovations was undisclosed. Other terms of the deal were not released.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.